Designer Drugs encompass chemical compounds designed for medical and scientific applications. Their use is restricted to research purposes until they undergo thorough testing to confirm their efficacy and safety. The issue arises when some of these substances exhibit psychoactive properties while remaining unlisted as prohibited substances. Consequently, „Legal Highs“ are often regarded as more hazardous than conventional drugs, though whether this perception holds true remains uncertain.
Designer Drugs is a story
A prime example is diacetylomorphine, which was synthesized in response to the delegations of its sister morphine. Another breakthrough was in the 1960s. And a big wave of psychedelics like DOM and ALD-52 came on the market shortly after the delegation of the then-popular drug. Then in the 1980s. There were opioid analogues and MDMA resyntheses, which are now being used in the experimental treatment of natural stress disorders, as well as in the treatment of left-neural nerve fibers or anti-psychotic societies.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.